200 related articles for article (PubMed ID: 32907879)
1. Proteolytic cleavage of Podocin by Matriptase exacerbates podocyte injury.
Ozawa S; Matsubayashi M; Nanaura H; Yanagita M; Mori K; Asanuma K; Kajiwara N; Hayashi K; Ohashi H; Kasahara M; Yokoi H; Kataoka H; Mori E; Nakagawa T
J Biol Chem; 2020 Nov; 295(47):16002-16012. PubMed ID: 32907879
[TBL] [Abstract][Full Text] [Related]
2. The protease inhibitor HAI-2, but not HAI-1, regulates matriptase activation and shedding through prostasin.
Friis S; Sales KU; Schafer JM; Vogel LK; Kataoka H; Bugge TH
J Biol Chem; 2014 Aug; 289(32):22319-32. PubMed ID: 24962579
[TBL] [Abstract][Full Text] [Related]
3. Hepatocyte growth factor activator inhibitor-2 prevents shedding of matriptase.
Larsen BR; Steffensen SD; Nielsen NV; Friis S; Godiksen S; Bornholdt J; Soendergaard C; Nonboe AW; Andersen MN; Poulsen SS; Szabo R; Bugge TH; Lin CY; Skovbjerg H; Jensen JK; Vogel LK
Exp Cell Res; 2013 Apr; 319(6):918-29. PubMed ID: 23333561
[TBL] [Abstract][Full Text] [Related]
4. Engineering a potent inhibitor of matriptase from the natural hepatocyte growth factor activator inhibitor type-1 (HAI-1) protein.
Mitchell AC; Kannan D; Hunter SA; Parra Sperberg RA; Chang CH; Cochran JR
J Biol Chem; 2018 Apr; 293(14):4969-4980. PubMed ID: 29386351
[TBL] [Abstract][Full Text] [Related]
5. Insights into the regulation of the matriptase-prostasin proteolytic system.
Holt-Danborg L; Skovbjerg S; Goderum KW; Nonboe AW; Stankevic E; Frost ÁK; Vitved L; Jensen JK; Vogel LK
Biochem J; 2020 Nov; 477(22):4349-4365. PubMed ID: 33094801
[TBL] [Abstract][Full Text] [Related]
6. Potent inhibition and global co-localization implicate the transmembrane Kunitz-type serine protease inhibitor hepatocyte growth factor activator inhibitor-2 in the regulation of epithelial matriptase activity.
Szabo R; Hobson JP; List K; Molinolo A; Lin CY; Bugge TH
J Biol Chem; 2008 Oct; 283(43):29495-504. PubMed ID: 18713750
[TBL] [Abstract][Full Text] [Related]
7. Cleavage of hepatocyte growth factor activator inhibitor-1 by membrane-type MMP-1 activates matriptase.
Domoto T; Takino T; Guo L; Sato H
Cancer Sci; 2012 Mar; 103(3):448-54. PubMed ID: 22118498
[TBL] [Abstract][Full Text] [Related]
8. The Kunitz Domain I of Hepatocyte Growth Factor Activator Inhibitor-2 Inhibits Matriptase Activity and Invasive Ability of Human Prostate Cancer Cells.
Wu SR; Teng CH; Tu YT; Ko CJ; Cheng TS; Lan SW; Lin HY; Lin HH; Tu HF; Hsiao PW; Huang HP; Chen CH; Lee MS
Sci Rep; 2017 Nov; 7(1):15101. PubMed ID: 29118397
[TBL] [Abstract][Full Text] [Related]
9. Crystal structures of matriptase in complex with its inhibitor hepatocyte growth factor activator inhibitor-1.
Zhao B; Yuan C; Li R; Qu D; Huang M; Ngo JC
J Biol Chem; 2013 Apr; 288(16):11155-64. PubMed ID: 23443661
[TBL] [Abstract][Full Text] [Related]
10. MYDGF attenuates podocyte injury and proteinuria by activating Akt/BAD signal pathway in mice with diabetic kidney disease.
He M; Li Y; Wang L; Guo B; Mei W; Zhu B; Zhang J; Ding Y; Meng B; Zhang L; Xiang L; Dong J; Liu M; Xiang L; Xiang G
Diabetologia; 2020 Sep; 63(9):1916-1931. PubMed ID: 32588068
[TBL] [Abstract][Full Text] [Related]
11. Regulation of pericellular proteolysis by hepatocyte growth factor activator inhibitor type 1 (HAI-1) in trophoblast cells.
Kohama K; Kawaguchi M; Fukushima T; Lin CY; Kataoka H
Hum Cell; 2012 Dec; 25(4):100-10. PubMed ID: 23248048
[TBL] [Abstract][Full Text] [Related]
12. 3-Cl-AHPC inhibits pro-HGF maturation by inducing matriptase/HAI-1 complex formation.
Ye F; Chen S; Liu X; Ye X; Wang K; Zeng Z; Su Y; Zhang XK; Zhou H
J Cell Mol Med; 2019 Jan; 23(1):155-166. PubMed ID: 30370662
[TBL] [Abstract][Full Text] [Related]
13. CIN85/RukL is a novel binding partner of nephrin and podocin and mediates slit diaphragm turnover in podocytes.
Tossidou I; Teng B; Drobot L; Meyer-Schwesinger C; Worthmann K; Haller H; Schiffer M
J Biol Chem; 2010 Aug; 285(33):25285-95. PubMed ID: 20457601
[TBL] [Abstract][Full Text] [Related]
14. Reduced prostasin (CAP1/PRSS8) activity eliminates HAI-1 and HAI-2 deficiency-associated developmental defects by preventing matriptase activation.
Szabo R; Uzzun Sales K; Kosa P; Shylo NA; Godiksen S; Hansen KK; Friis S; Gutkind JS; Vogel LK; Hummler E; Camerer E; Bugge TH
PLoS Genet; 2012; 8(8):e1002937. PubMed ID: 22952456
[TBL] [Abstract][Full Text] [Related]
15. c-Cbl induced podocin ubiquitination contributes to the podocytes injury in diabetic nephropathy.
Liang L; He M; Zhou P; Pan S; Chen J; Lv L; Hu M; Zhou S; Liu D; Liu Z
FASEB J; 2024 May; 38(10):e23662. PubMed ID: 38752545
[TBL] [Abstract][Full Text] [Related]
16. Podocin is translocated to cytoplasm in puromycin aminonucleoside nephrosis rats and in poor-prognosis patients with IgA nephropathy.
Fukuda H; Hidaka T; Takagi-Akiba M; Ichimura K; Oliva Trejo JA; Sasaki Y; Wang J; Sakai T; Asanuma K; Tomino Y
Cell Tissue Res; 2015 May; 360(2):391-400. PubMed ID: 25676004
[TBL] [Abstract][Full Text] [Related]
17. Imbalanced matriptase pericellular proteolysis contributes to the pathogenesis of malignant B-cell lymphomas.
Chou FP; Chen YW; Zhao XF; Xu-Monette ZY; Young KH; Gartenhaus RB; Wang JK; Kataoka H; Zuo AH; Barndt RJ; Johnson M; Lin CY
Am J Pathol; 2013 Oct; 183(4):1306-17. PubMed ID: 24070417
[TBL] [Abstract][Full Text] [Related]
18. ATP acting through P2Y receptors causes activation of podocyte TRPC6 channels: role of podocin and reactive oxygen species.
Roshanravan H; Dryer SE
Am J Physiol Renal Physiol; 2014 May; 306(9):F1088-97. PubMed ID: 24553432
[TBL] [Abstract][Full Text] [Related]
19. Targeted deletion of HAI-1 increases prostasin proteolysis but decreases matriptase proteolysis in human keratinocytes.
Lu DD; Gu Y; Li SA; Barndt RJ; Huang SM; Wang JK; Su HC; Johnson MD; Lin CY
Hum Cell; 2021 May; 34(3):771-784. PubMed ID: 33486722
[TBL] [Abstract][Full Text] [Related]
20. Loss of hepatocyte growth factor activator inhibitor type 1 participates in metastatic spreading of human pancreatic cancer cells in a mouse orthotopic transplantation model.
Ye J; Kawaguchi M; Haruyama Y; Kanemaru A; Fukushima T; Yamamoto K; Lin CY; Kataoka H
Cancer Sci; 2014 Jan; 105(1):44-51. PubMed ID: 24147538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
